This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 113/17/2120    most recent CIRCULATIONAHA.105.595249v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zernecke, A. Articles by Weber, C. Search for Related Content PubMed PubMed Citation Articles by Zernecke, A. Articles by Weber, C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Vasculitis Related Collections Animal models of human disease Genetically altered mice Physiological and pathological control of gene expression Other Vascular biology

(Circulation. 2006;113:2120-2127.)
© 2006 American Heart Association, Inc.

Vascular Medicine

CD73/Ecto-5'-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation

Alma Zernecke, MD; Kiril Bidzhekov, PhD; Burcin Özüyaman, MD; Line Fraemohs, MSc; Elisa A. Liehn, MD; Juliane M. Lüscher-Firzlaff, MD; Bernhard Lüscher, PhD; Jürgen Schrader, MD; Christian Weber, MD

From the Institute of Molecular Cardiovascular Research (A.Z., K.B., B.Ö., L.F., E.A.L., C.W.) and the Division of Biochemistry and Molecular Biology (J.M.L.-F., B.L.), Rheinisch-Westfälische Technisch Hochschule (RWTH University), Aachen, Germany, and the Institute of Cardiovascular Physiology (B.Ö., J.S.), Heinrich-Heine University, Düsseldorf, Germany.

Correspondence to Dr Christian Weber, Institut für Kardiovaskuläre Molekularbiologie, Universitätsklinikum Aachen, Pauwelsstraße 30, 52074 Aachen, Germany. E-mail cweber{at}ukaachen.de

Received October 13, 2005; revision received February 28, 2006; accepted March 2, 2006.

Background— Although CD73/ecto-5'-nucleotidase has been implicated in maintaining vasoprotection, its role in regulating endothelial adhesion molecule or inflammatory monocyte recruitment (eg, in the context of vascular injury) remains to be defined.

Methods and Results— Compared with wild-type mice, CD73-deficient (CD73^–/–) mice exhibit increased luminal staining and protein and transcript expression for vascular cell adhesion molecule (VCAM)-1 in carotid arteries. In vitro, aortic endothelial cells (ECs) from CD73^–/– mice display an upregulation of mRNA and protein expression of VCAM-1, associated with increased nuclear factor (NF)-B activity, as determined by chromatin cross-linking and immunoprecipitation or quantitative p65 binding assays. CD73^–/– ECs and carotid arteries perfused ex vivo supported increased monocyte arrest under flow conditions, which was mediated by _4ß1 integrin. After wire injury of carotid arteries, CD73 expression and activity were upregulated in wild-type mice, whereas neointimal plaque formation and macrophage content were increased in CD73^–/– mice versus wild-type mice, concomitant with elevated NF-B activation, luminal VCAM-1 expression, and soluble VCAM-1 concentrations. In contrast, reconstitution of wild-type mice with CD73^–/– versus CD73^+/+ BM did not significantly exacerbate neointima formation. Treatment with the specific A_2A receptor agonist ATL-146e reversed the increased VCAM-1 transcript and protein expression in CD73^–/– ECs and inhibited monocyte arrest on CD73^–/– ECs. Continuous infusion of ATL-146e prevented neointima formation in CD73^–/– mice.

Conclusions— Our data epitomize the importance of vascular CD73 in limiting endothelial activation and monocyte recruitment via generation of adenosine acting through the A_2A receptor, providing a molecular basis for therapeutic protection against vascular inflammation and neointimal hyperplasia.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				A. Zernecke, K. Bidzhekov, H. Noels, E. Shagdarsuren, L. Gan, B. Denecke, M. Hristov, T. Koppel, M. N. Jahantigh, E. Lutgens, et al. Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection Sci. Signal., December 8, 2009; 2(100): ra81 - ra81. [Abstract] [Full Text] [PDF]

				P. Meijer, W. J.G. Oyen, D. Dekker, P. H.H. van den Broek, C. W. Wouters, O. C. Boerman, G. J. Scheffer, P. Smits, and G. A. Rongen Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 963 - 968. [Abstract] [Full Text] [PDF]

				M. Katebi, M. Soleimani, and B. N. Cronstein Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development J. Leukoc. Biol., March 1, 2009; 85(3): 438 - 444. [Abstract] [Full Text] [PDF]

				L. Landsman, L. Bar-On, A. Zernecke, K.-W. Kim, R. Krauthgamer, E. Shagdarsuren, S. A. Lira, I. L. Weissman, C. Weber, and S. Jung CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival Blood, January 22, 2009; 113(4): 963 - 972. [Abstract] [Full Text] [PDF]

				T. Hasegawa, D. Bouis, H. Liao, S. H. Visovatti, and D. J. Pinsky Ecto-5' Nucleotidase (CD73)-Mediated Adenosine Generation and Signaling in Murine Cardiac Allograft Vasculopathy Circ. Res., December 5, 2008; 103(12): 1410 - 1421. [Abstract] [Full Text] [PDF]

				M. L. Hart, D. Kohler, T. Eckle, D. Kloor, G. L. Stahl, and H. K. Eltzschig Direct Treatment of Mouse or Human Blood With Soluble 5'-Nucleotidase Inhibits Platelet Aggregation Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1477 - 1483. [Abstract] [Full Text] [PDF]

				J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis PNAS, July 8, 2008; 105(27): 9325 - 9330. [Abstract] [Full Text] [PDF]

				X. Xu, J. Fassett, X. Hu, G. Zhu, Z. Lu, Y. Li, J. Schnermann, R. J. Bache, and Y. Chen Ecto-5'-Nucleotidase Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction Hypertension, June 1, 2008; 51(6): 1557 - 1564. [Abstract] [Full Text] [PDF]

				M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. L. Joachims, S. T. McGee, E. Maeda, R. P. McEver, T. Tanaka, M. Miyasaka, et al. CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes J. Immunol., May 1, 2008; 180(9): 6288 - 6296. [Abstract] [Full Text] [PDF]

				N. A. Louis, A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan Control of IFN-{alpha}A by CD73: Implications for Mucosal Inflammation J. Immunol., March 15, 2008; 180(6): 4246 - 4255. [Abstract] [Full Text] [PDF]

				S. Jalkanen and M. Salmi VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 18 - 26. [Abstract] [Full Text] [PDF]

				A. E. Lomax, M. O'Reilly, S. Neshat, and S. J. Vanner Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis J. Physiol., September 1, 2007; 583(2): 719 - 730. [Abstract] [Full Text] [PDF]

				P. von Hundelshausen and C. Weber Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease Circ. Res., January 5, 2007; 100(1): 27 - 40. [Abstract] [Full Text] [PDF]